Navigation
Recherche
|
The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls
lundi 16 décembre 2024, 22:01 , par BoingBoing
Biopharma firm Mind Medicine announced that they have dosed the first-ever patient in a Phase 3 clinical trial of LSD. The individual tripped on lysergide D-tartrate, an LSD formulation for which the US FDA granted 'breakthrough therapy' status in March as a promising treatment for generalized anxiety disorder (GAD). — Read the rest The post The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls appeared first on Boing Boing.
https://boingboing.net/2024/12/16/the-first-ever-patient-in-a-phase-3-medical-study-of-lsd-has-succe...
Voir aussi |
56 sources (32 en français)
Date Actuelle
mer. 18 déc. - 16:03 CET
|